ADL
ANAB icon

Asset Dedication LLC’s AnaptysBio ANAB Stock Holding History

Asset Dedication LLC’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-190
Closed -$2.52K – 1131
2024
Q4 		$2.52K Hold
190
– – ﹤0.01% 949
2024
Q3 		$6.37K Buy
+190
New +$6.49K ﹤0.01% 866

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Asset Dedication LLC's ANAB Position: Q1 2025 in Review

Asset Dedication LLC sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 190 shares — an estimated $2.52K sold.

Asset Dedication LLC first reported a position in ANAB in Q3 2024 and held it in 2 quarters. The position peaked at $6.37K in Q3 2024. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

  • Asset Dedication LLC reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
  • Asset Dedication LLC sold 190 AnaptysBio shares in Q1 2025, an estimated $2.52K.
  • Asset Dedication LLC first reported a position in AnaptysBio in Q3 2024 and held it in 2 quarters.
  • Asset Dedication LLC's AnaptysBio position peaked at $6.37K in Q3 2024.
  • 153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on Asset Dedication LLC's 13F filing for Q1 2025, filed 1 May 2025.